The potential of positron-emission tomography for pharmacokinetic and pharmacodynamic studies of neuroleptics.
Farde
L
L
Department of Psychiatry and Psychology, Karolinska Institute and Hospital, Stockholm, Sweden.
Wiesel
F A
FA
Nilsson
L
L
Sedvall
G
G
D014150:Antipsychotic Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology; D001798:Blood Proteins / Q000378:metabolism; D001923:Brain Chemistry; D006801:Humans; D011485:Protein Binding; D020891:Raclopride; D011954:Receptors, Dopamine / Q000032:analysis / Q000187:drug effects / Q000378:metabolism; D012457:Salicylamides / Q000378:metabolism; D012559:Schizophrenia / Q000378:metabolism; D014055:Tomography, Emission-Computed
D014150:Antipsychotic Agents; D001798:Blood Proteins; D011954:Receptors, Dopamine; D012457:Salicylamides; C028051:neuroleptic receptor; D020891:Raclopride